← Back to Search

Multifocal Contact Lens

Extended Depth of Focus Lenses for Presbyopia

Phase 4
Recruiting
Research Sponsored by Visioneering Technologies, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 hours
Awards & highlights

Study Summary

This trial is testing a new contact lens that provides clear distance, intermediate, and near vision. The goal is to quantify the benefits of this new lens design.

Who is the study for?
This trial is for people who need a reading prescription of +2.00 or stronger, can comfortably wear contact lenses, and have normal vision (20/25 or better) when corrected with glasses or contacts. It's not suitable for those with eye conditions that make wearing lenses unsafe.Check my eligibility
What is being tested?
The study tests NaturalVue Multifocal contact lenses designed to improve depth of focus for clearer vision at all distances in individuals with presbyopia. The goal is to measure the effectiveness of these lenses in providing enhanced visual acuity.See study design
What are the potential side effects?
While specific side effects are not listed, typical contact lens use may cause dry eyes, discomfort, redness, and potential infection if not used properly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
LogMAR Visual Acuity

Trial Design

1Treatment groups
Experimental Treatment
Group I: PresbyopiaExperimental Treatment1 Intervention
Subject's baseline vision will be compared with vision wearing treatment product

Find a Location

Who is running the clinical trial?

Visioneering Technologies, IncLead Sponsor
2 Previous Clinical Trials
224 Total Patients Enrolled

Media Library

NaturalVue Multifocal (Multifocal Contact Lens) Clinical Trial Eligibility Overview. Trial Name: NCT05495971 — Phase 4
Presbyopia Research Study Groups: Presbyopia
Presbyopia Clinical Trial 2023: NaturalVue Multifocal Highlights & Side Effects. Trial Name: NCT05495971 — Phase 4
NaturalVue Multifocal (Multifocal Contact Lens) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05495971 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining vacancies in this research initiative?

"Affirmative. According to the information posted on clinicaltrials.gov, this medical trial was initial published on September 6th 2022 and is still actively looking for participants as of October 3rd 2022. The study requires a total of 50 patients from one centre."

Answered by AI

What is the current enrollment figure for this investigation?

"Correct. Clinicaltrials.gov data shows that this research endeavor, originally posted on September 6th 2022 is presently recruiting individuals to participate in the trial. At present, 50 patients are needed from a solitary clinical site."

Answered by AI

Are applicants aged 35 and up eligible to participate in this trial?

"This research study is looking for participants aged 45 to 70."

Answered by AI

What potential risks might be associated with NaturalVue Multifocal?

"The safety profile of NaturalVue Multifocal was assigned a score of 3 due to the Phase 4 status, indicating it is approved for use."

Answered by AI

Who meets the qualifications to be a participant in this experiment?

"The aim of this research is to recruit 50 individuals aged between 45 and 70 who suffer from presbyopia. It should also be noted that potential participants must have normal corrected vision, the capacity to wear contact lenses, and a need for reading glasses with strength greater than +2.00 diopters."

Answered by AI

Who else is applying?

What state do they live in?
Texas
What site did they apply to?
VTI
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

Help for better vision.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Extended Depth of Focus Contact Lenses for Presbyopia
2022. "Extended Depth of Focus Contact Lenses for Presbyopia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05495971.
All > Presbyopia
~13 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top